Quote For Merck & Co., Inc. MRK.N
sector: Healthcare ·
industry: Pharmaceuticals - Diversified ·
As of
23 Nov 2009
36.42USD
$36.42
23 Nov 2009
-0.11%
$36.46
$36.65
8,136,100
$36.95
$36.20
$36.67
$20.05
0.95
22,135,774
News
Press Releases
Key Developments
Officers
| Name |
Current Position |
Compensation |
| Clark, Richard |
Chairman of the Board, President, Chief Executive Officer |
19,906,430 |
| Kellogg, Peter |
Chief Financial Officer, Executive Vice President |
3,819,080 |
| Schechter, Adam |
President - Global Pharmaceuticals |
-- |
Key Ratios and Statistics
| Share Related Items |
| Market Cap (Mil.) |
$111,366.20 |
| Shares Outstanding (Mil.) |
3,054.48 |
| Float (Mil.) |
3,028.70 |
| |
| Dividend Information |
| Yield % |
4.17 |
| Annual Dividend ($ USD) |
1.52 |
| Payout Ratio(TTM) % |
39.91 |
| |
| Financial Strength |
| Quick Ratio |
1.19 |
| Current Ratio |
3.70 |
| LT Debt/Equity |
35.82 |
| Total Debt/Equity |
39.60 |
| |
| Valuation Ratios |
| Price/Earnings(TTM) |
9.59 |
| Price/Sales(TTM) |
4.77 |
| Price/Book(TTM) |
3.36 |
| Price/Cash Flow(TTM) |
11.20 |
| |
|
| Per Share Data |
| Earnings(TTM) |
$3.81 |
| Sales(TTM) |
$11.07 |
| Book Value(MRQ) |
$10.86 |
| Cash Flow(TTM) |
$4.71 |
| Cash(MRQ) |
$10.55 |
|
| Management Effectiveness |
| Return on Equity(TTM) |
37.81 |
| Return on Assets(TTM) |
16.74 |
| Return on Investment(TTM) |
23.29 |
| |
|
| Margins |
| Gross Margin(TTM) % |
76.38 |
| Operating Margin(TTM) % |
46.02 |
| Profit Margin(TTM) % |
34.85 |
|
| |
|
UK
US
- Europe
- Asia
- UK Most Actives